Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Accidental Falls | 57 | 2024 | 1066 | 6.760 |
Why?
|
Postural Balance | 40 | 2023 | 621 | 5.470 |
Why?
|
Hypotension, Orthostatic | 38 | 2024 | 258 | 5.090 |
Why?
|
Cerebrovascular Circulation | 38 | 2024 | 2728 | 4.580 |
Why?
|
Nursing Homes | 47 | 2023 | 1081 | 3.970 |
Why?
|
Aging | 78 | 2024 | 8689 | 3.670 |
Why?
|
Gait | 23 | 2023 | 816 | 3.310 |
Why?
|
Independent Living | 18 | 2023 | 579 | 3.300 |
Why?
|
Tai Ji | 13 | 2023 | 287 | 2.730 |
Why?
|
Blood Pressure | 77 | 2023 | 8479 | 2.700 |
Why?
|
Hypertension | 43 | 2023 | 8527 | 2.420 |
Why?
|
Geriatric Assessment | 36 | 2019 | 1409 | 2.390 |
Why?
|
Frail Elderly | 27 | 2019 | 761 | 2.160 |
Why?
|
Cognition | 36 | 2023 | 6973 | 2.070 |
Why?
|
Blood Flow Velocity | 19 | 2020 | 1370 | 2.060 |
Why?
|
Posture | 31 | 2023 | 955 | 2.000 |
Why?
|
Homes for the Aged | 21 | 2020 | 272 | 1.910 |
Why?
|
Syncope | 26 | 2023 | 427 | 1.870 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 4 | 2018 | 691 | 1.800 |
Why?
|
Walking | 13 | 2023 | 1199 | 1.780 |
Why?
|
Ultrasonography, Doppler, Transcranial | 15 | 2020 | 281 | 1.700 |
Why?
|
Aged, 80 and over | 186 | 2024 | 58859 | 1.660 |
Why?
|
Skilled Nursing Facilities | 10 | 2024 | 395 | 1.600 |
Why?
|
Aged | 301 | 2024 | 168840 | 1.580 |
Why?
|
Videoconferencing | 6 | 2024 | 203 | 1.480 |
Why?
|
Activities of Daily Living | 30 | 2019 | 2420 | 1.450 |
Why?
|
Mobility Limitation | 7 | 2016 | 408 | 1.300 |
Why?
|
Antihypertensive Agents | 15 | 2022 | 2018 | 1.270 |
Why?
|
Middle Cerebral Artery | 13 | 2020 | 275 | 1.250 |
Why?
|
Hypotension | 19 | 2023 | 879 | 1.240 |
Why?
|
Cognition Disorders | 17 | 2017 | 3975 | 1.210 |
Why?
|
Regional Blood Flow | 6 | 2015 | 1487 | 1.160 |
Why?
|
Psychomotor Performance | 9 | 2021 | 1880 | 1.020 |
Why?
|
Executive Function | 7 | 2024 | 1383 | 0.930 |
Why?
|
Male | 247 | 2024 | 360035 | 0.910 |
Why?
|
Disability Evaluation | 9 | 2019 | 1834 | 0.900 |
Why?
|
Housing for the Elderly | 4 | 2019 | 17 | 0.890 |
Why?
|
Humans | 360 | 2024 | 760437 | 0.880 |
Why?
|
Autonomic Nervous System | 10 | 2012 | 701 | 0.870 |
Why?
|
Female | 253 | 2024 | 391875 | 0.860 |
Why?
|
Foot | 11 | 2018 | 574 | 0.860 |
Why?
|
Geriatrics | 8 | 2023 | 388 | 0.850 |
Why?
|
Somatosensory Disorders | 3 | 2012 | 49 | 0.820 |
Why?
|
Gait Disorders, Neurologic | 3 | 2021 | 240 | 0.820 |
Why?
|
Vascular Resistance | 10 | 2017 | 932 | 0.820 |
Why?
|
Siderophores | 2 | 2015 | 61 | 0.810 |
Why?
|
Deferoxamine | 2 | 2015 | 154 | 0.800 |
Why?
|
Heart Rate | 30 | 2019 | 4190 | 0.800 |
Why?
|
Infection Control | 4 | 2022 | 985 | 0.780 |
Why?
|
Hypoxia-Inducible Factor 1 | 2 | 2015 | 193 | 0.780 |
Why?
|
Health Education | 2 | 2019 | 1052 | 0.770 |
Why?
|
Long-Term Care | 12 | 2018 | 633 | 0.760 |
Why?
|
Nonlinear Dynamics | 5 | 2012 | 493 | 0.750 |
Why?
|
Hospitals, Community | 1 | 2023 | 365 | 0.740 |
Why?
|
Blood Pressure Determination | 11 | 2023 | 634 | 0.740 |
Why?
|
Patient Transfer | 5 | 2024 | 793 | 0.730 |
Why?
|
Dementia | 8 | 2023 | 2679 | 0.700 |
Why?
|
Vibration | 6 | 2018 | 328 | 0.690 |
Why?
|
Attention | 8 | 2023 | 2391 | 0.690 |
Why?
|
Public Housing | 2 | 2020 | 140 | 0.680 |
Why?
|
Vestibular Diseases | 2 | 2020 | 230 | 0.660 |
Why?
|
Vascular Malformations | 2 | 2015 | 468 | 0.650 |
Why?
|
Prospective Studies | 59 | 2023 | 54339 | 0.630 |
Why?
|
Amlodipine | 1 | 2018 | 84 | 0.620 |
Why?
|
Hemodynamics | 14 | 2024 | 4167 | 0.620 |
Why?
|
Boston | 28 | 2022 | 9326 | 0.610 |
Why?
|
Metoprolol | 1 | 2018 | 90 | 0.610 |
Why?
|
Vasomotor System | 4 | 2006 | 207 | 0.600 |
Why?
|
Ramipril | 1 | 2018 | 102 | 0.600 |
Why?
|
Health Services for the Aged | 4 | 2021 | 259 | 0.590 |
Why?
|
Shoes | 3 | 2014 | 94 | 0.590 |
Why?
|
Cultural Diversity | 1 | 2021 | 368 | 0.590 |
Why?
|
Baroreflex | 6 | 2020 | 149 | 0.580 |
Why?
|
Eating | 13 | 2000 | 1535 | 0.570 |
Why?
|
Task Performance and Analysis | 4 | 2021 | 760 | 0.570 |
Why?
|
Trail Making Test | 3 | 2018 | 57 | 0.570 |
Why?
|
Adaptation, Physiological | 3 | 2012 | 1301 | 0.570 |
Why?
|
Benzimidazoles | 2 | 2013 | 855 | 0.560 |
Why?
|
Risk Factors | 73 | 2024 | 74055 | 0.560 |
Why?
|
Renin-Angiotensin System | 3 | 2010 | 737 | 0.560 |
Why?
|
Fractals | 5 | 2017 | 128 | 0.550 |
Why?
|
Prefrontal Cortex | 5 | 2024 | 2218 | 0.540 |
Why?
|
Tetrazoles | 2 | 2013 | 907 | 0.540 |
Why?
|
Social Support | 4 | 2021 | 2167 | 0.540 |
Why?
|
Motor Skills | 2 | 2018 | 520 | 0.530 |
Why?
|
Muscle Contraction | 2 | 2021 | 1197 | 0.520 |
Why?
|
Noise | 4 | 2016 | 289 | 0.520 |
Why?
|
Depression | 8 | 2015 | 8104 | 0.520 |
Why?
|
Delirium | 11 | 2019 | 1667 | 0.500 |
Why?
|
Insurance, Long-Term Care | 1 | 2015 | 18 | 0.500 |
Why?
|
Corpus Callosum | 1 | 2020 | 749 | 0.500 |
Why?
|
Chelation Therapy | 1 | 2015 | 77 | 0.500 |
Why?
|
Retinal Diseases | 2 | 2011 | 704 | 0.490 |
Why?
|
Monitoring, Ambulatory | 2 | 2016 | 354 | 0.480 |
Why?
|
Sensory Aids | 1 | 2014 | 40 | 0.480 |
Why?
|
Brain | 20 | 2024 | 27060 | 0.480 |
Why?
|
Central Nervous System | 4 | 2016 | 1337 | 0.470 |
Why?
|
Restraint, Physical | 1 | 2016 | 186 | 0.470 |
Why?
|
Interprofessional Relations | 1 | 2020 | 991 | 0.460 |
Why?
|
Continuity of Patient Care | 3 | 2024 | 1069 | 0.460 |
Why?
|
Respiration | 9 | 2015 | 1657 | 0.460 |
Why?
|
Lisinopril | 2 | 2012 | 61 | 0.460 |
Why?
|
Hydrochlorothiazide | 2 | 2012 | 94 | 0.450 |
Why?
|
Cardiovascular Diseases | 13 | 2024 | 15476 | 0.450 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2015 | 748 | 0.450 |
Why?
|
Patient Readmission | 4 | 2023 | 3249 | 0.440 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2019 | 1554 | 0.440 |
Why?
|
Massachusetts | 8 | 2022 | 8826 | 0.440 |
Why?
|
Renin | 2 | 2014 | 639 | 0.440 |
Why?
|
Resilience, Psychological | 1 | 2021 | 787 | 0.430 |
Why?
|
Recovery of Function | 4 | 2019 | 2975 | 0.430 |
Why?
|
Muscle Tonus | 1 | 2013 | 82 | 0.430 |
Why?
|
Longitudinal Studies | 18 | 2023 | 14565 | 0.430 |
Why?
|
Physical Therapy Modalities | 3 | 2021 | 536 | 0.430 |
Why?
|
Lower Extremity | 2 | 2021 | 1199 | 0.420 |
Why?
|
Physiological Phenomena | 1 | 2012 | 18 | 0.420 |
Why?
|
Erythropoietin | 2 | 2015 | 719 | 0.420 |
Why?
|
Signal Processing, Computer-Assisted | 4 | 2013 | 1496 | 0.410 |
Why?
|
Quality of Life | 8 | 2022 | 13338 | 0.410 |
Why?
|
Patient Care Planning | 2 | 2014 | 908 | 0.410 |
Why?
|
Rehabilitation | 1 | 2013 | 129 | 0.410 |
Why?
|
Particulate Matter | 3 | 2014 | 2582 | 0.410 |
Why?
|
Acceleration | 2 | 2022 | 189 | 0.400 |
Why?
|
Reflex | 3 | 2013 | 376 | 0.400 |
Why?
|
Flavonols | 2 | 2023 | 85 | 0.400 |
Why?
|
Homeostasis | 16 | 2022 | 3320 | 0.400 |
Why?
|
Remote Consultation | 1 | 2014 | 237 | 0.390 |
Why?
|
Nerve Fibers, Myelinated | 4 | 2013 | 952 | 0.390 |
Why?
|
Emergency Service, Hospital | 10 | 2017 | 7860 | 0.390 |
Why?
|
Exercise | 6 | 2024 | 5874 | 0.380 |
Why?
|
Vasodilator Agents | 3 | 2009 | 973 | 0.380 |
Why?
|
Age Factors | 30 | 2024 | 18379 | 0.380 |
Why?
|
Intelligence | 3 | 2011 | 924 | 0.380 |
Why?
|
Prevalence | 20 | 2022 | 15698 | 0.380 |
Why?
|
Patient Discharge | 7 | 2024 | 3436 | 0.380 |
Why?
|
Length of Stay | 7 | 2023 | 6413 | 0.380 |
Why?
|
Sensation Disorders | 3 | 2009 | 160 | 0.380 |
Why?
|
Disabled Persons | 3 | 2013 | 1224 | 0.380 |
Why?
|
Models, Cardiovascular | 6 | 2009 | 985 | 0.370 |
Why?
|
Middle Aged | 90 | 2024 | 220382 | 0.370 |
Why?
|
Reaction Time | 2 | 2015 | 2078 | 0.370 |
Why?
|
Aldosterone | 2 | 2014 | 866 | 0.360 |
Why?
|
Syncope, Vasovagal | 4 | 2011 | 38 | 0.360 |
Why?
|
Proprioception | 3 | 2003 | 133 | 0.360 |
Why?
|
Apolipoprotein E4 | 2 | 2015 | 706 | 0.360 |
Why?
|
Residence Characteristics | 6 | 2014 | 2087 | 0.350 |
Why?
|
Analgesics | 4 | 2006 | 1070 | 0.350 |
Why?
|
Government Regulation | 2 | 2013 | 524 | 0.340 |
Why?
|
Carotid Arteries | 2 | 2005 | 941 | 0.340 |
Why?
|
Neuropsychological Tests | 12 | 2018 | 7029 | 0.330 |
Why?
|
Cross-Over Studies | 9 | 2018 | 2073 | 0.330 |
Why?
|
Nerve Net | 2 | 2018 | 2283 | 0.330 |
Why?
|
Stochastic Processes | 5 | 2013 | 356 | 0.330 |
Why?
|
Chronic Disease | 6 | 2019 | 9309 | 0.330 |
Why?
|
Double-Blind Method | 14 | 2021 | 12320 | 0.320 |
Why?
|
Analysis of Variance | 17 | 2010 | 6230 | 0.320 |
Why?
|
Models, Organizational | 1 | 2012 | 546 | 0.320 |
Why?
|
Microcirculation | 5 | 2014 | 1269 | 0.320 |
Why?
|
Models, Biological | 6 | 2010 | 9462 | 0.320 |
Why?
|
Quality Improvement | 3 | 2021 | 3798 | 0.320 |
Why?
|
Intracranial Hemorrhage, Traumatic | 1 | 2009 | 54 | 0.320 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 6 | 2015 | 1517 | 0.310 |
Why?
|
Pressure Ulcer | 5 | 1999 | 156 | 0.310 |
Why?
|
Risk Assessment | 15 | 2022 | 23953 | 0.310 |
Why?
|
Orthotic Devices | 1 | 2009 | 129 | 0.310 |
Why?
|
Touch | 3 | 2012 | 312 | 0.310 |
Why?
|
Parkinson Disease | 6 | 2021 | 2875 | 0.310 |
Why?
|
Subacute Care | 2 | 2024 | 178 | 0.310 |
Why?
|
Enteral Nutrition | 3 | 2000 | 792 | 0.300 |
Why?
|
Caregivers | 5 | 2022 | 2232 | 0.300 |
Why?
|
Cohort Studies | 30 | 2018 | 41366 | 0.300 |
Why?
|
Cross-Sectional Studies | 28 | 2023 | 26063 | 0.300 |
Why?
|
Environment | 4 | 2015 | 1122 | 0.290 |
Why?
|
Health Status | 5 | 2017 | 4071 | 0.290 |
Why?
|
Health Personnel | 1 | 2021 | 3331 | 0.290 |
Why?
|
Follow-Up Studies | 21 | 2023 | 39078 | 0.290 |
Why?
|
Single-Blind Method | 3 | 2017 | 1571 | 0.290 |
Why?
|
Antidepressive Agents | 4 | 2013 | 2897 | 0.290 |
Why?
|
Sleep | 1 | 2023 | 4760 | 0.290 |
Why?
|
Adiponectin | 1 | 2013 | 1113 | 0.280 |
Why?
|
Poverty | 1 | 2019 | 2694 | 0.280 |
Why?
|
Life Expectancy | 1 | 2014 | 1240 | 0.280 |
Why?
|
Sensory Thresholds | 4 | 2018 | 377 | 0.280 |
Why?
|
Disease Susceptibility | 3 | 2015 | 1790 | 0.280 |
Why?
|
Mortality | 2 | 2018 | 2897 | 0.280 |
Why?
|
Health | 2 | 2017 | 398 | 0.280 |
Why?
|
Educational Status | 3 | 2012 | 2518 | 0.270 |
Why?
|
Dizziness | 4 | 2023 | 259 | 0.270 |
Why?
|
Pain | 5 | 2008 | 5075 | 0.270 |
Why?
|
Autonomic Nervous System Diseases | 3 | 2009 | 269 | 0.270 |
Why?
|
Isosorbide Dinitrate | 2 | 1996 | 34 | 0.260 |
Why?
|
Delivery of Health Care | 4 | 2017 | 5332 | 0.260 |
Why?
|
Health Transition | 1 | 2005 | 35 | 0.260 |
Why?
|
Maine | 3 | 2016 | 147 | 0.260 |
Why?
|
Nicardipine | 2 | 1996 | 60 | 0.260 |
Why?
|
Antipsychotic Agents | 2 | 2016 | 3066 | 0.260 |
Why?
|
Pilot Projects | 11 | 2021 | 8611 | 0.250 |
Why?
|
Electrocardiography | 13 | 2014 | 6380 | 0.250 |
Why?
|
Medicare | 6 | 2023 | 6732 | 0.250 |
Why?
|
Carotid Artery Diseases | 1 | 2011 | 872 | 0.250 |
Why?
|
Retinal Vessels | 1 | 2011 | 851 | 0.250 |
Why?
|
Sex Characteristics | 4 | 2013 | 2633 | 0.250 |
Why?
|
Time Factors | 22 | 2019 | 39947 | 0.240 |
Why?
|
Forecasting | 1 | 2014 | 2925 | 0.240 |
Why?
|
Systems Biology | 1 | 2008 | 481 | 0.240 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 3 | 2015 | 431 | 0.240 |
Why?
|
Artifacts | 1 | 2013 | 1898 | 0.230 |
Why?
|
Mathematics | 4 | 2010 | 707 | 0.230 |
Why?
|
Frontal Lobe | 3 | 2011 | 1420 | 0.230 |
Why?
|
Supine Position | 5 | 2006 | 205 | 0.230 |
Why?
|
Motivation | 2 | 2011 | 2006 | 0.230 |
Why?
|
Mood Disorders | 1 | 2011 | 1127 | 0.230 |
Why?
|
Magnetic Resonance Imaging | 13 | 2021 | 36362 | 0.230 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2020 | 10180 | 0.230 |
Why?
|
Regression Analysis | 13 | 2010 | 6340 | 0.230 |
Why?
|
United States | 30 | 2023 | 72202 | 0.230 |
Why?
|
Cerebrovascular Disorders | 5 | 2024 | 1475 | 0.220 |
Why?
|
Mental Health | 2 | 2017 | 3241 | 0.220 |
Why?
|
Carbon Dioxide | 5 | 2015 | 1146 | 0.220 |
Why?
|
Ferrets | 2 | 2001 | 177 | 0.220 |
Why?
|
Adult | 68 | 2024 | 220781 | 0.220 |
Why?
|
Comorbidity | 13 | 2018 | 10494 | 0.220 |
Why?
|
Vision Disorders | 1 | 2010 | 1088 | 0.210 |
Why?
|
Family | 3 | 2018 | 3189 | 0.210 |
Why?
|
Nervous System Physiological Phenomena | 2 | 2002 | 115 | 0.210 |
Why?
|
Stress, Physiological | 2 | 2008 | 1400 | 0.210 |
Why?
|
Accidents, Home | 3 | 2015 | 71 | 0.210 |
Why?
|
Quercetin | 1 | 2023 | 97 | 0.210 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2015 | 10759 | 0.210 |
Why?
|
Polymorphism, Genetic | 2 | 2010 | 4287 | 0.210 |
Why?
|
Checklist | 2 | 2020 | 827 | 0.210 |
Why?
|
Neuroprotective Agents | 1 | 2009 | 957 | 0.200 |
Why?
|
Air Pollution | 2 | 2014 | 2342 | 0.200 |
Why?
|
Homocysteine | 1 | 2005 | 638 | 0.200 |
Why?
|
Somatosensory Cortex | 3 | 2018 | 511 | 0.200 |
Why?
|
Estrogen Replacement Therapy | 2 | 2001 | 1208 | 0.200 |
Why?
|
Insurance Coverage | 1 | 2013 | 1934 | 0.200 |
Why?
|
Stroke | 10 | 2024 | 9745 | 0.200 |
Why?
|
Logistic Models | 15 | 2014 | 13240 | 0.200 |
Why?
|
Fever | 2 | 2000 | 1618 | 0.190 |
Why?
|
Hospitalization | 13 | 2015 | 10698 | 0.190 |
Why?
|
Fludrocortisone | 2 | 2013 | 24 | 0.190 |
Why?
|
Midodrine | 2 | 2013 | 24 | 0.190 |
Why?
|
Hospitals, Teaching | 3 | 2023 | 1155 | 0.180 |
Why?
|
Clinical Audit | 1 | 2020 | 29 | 0.180 |
Why?
|
Movement | 4 | 2008 | 1478 | 0.180 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 2 | 2011 | 53 | 0.180 |
Why?
|
Systole | 6 | 2007 | 937 | 0.180 |
Why?
|
Head-Down Tilt | 2 | 1997 | 65 | 0.180 |
Why?
|
Sex Factors | 12 | 2019 | 10538 | 0.180 |
Why?
|
Hip Joint | 3 | 2010 | 1013 | 0.180 |
Why?
|
Anisotropy | 3 | 2020 | 1283 | 0.170 |
Why?
|
Leukoencephalopathies | 2 | 2013 | 252 | 0.170 |
Why?
|
Models, Statistical | 6 | 2017 | 5078 | 0.170 |
Why?
|
Diuretics | 4 | 2015 | 610 | 0.170 |
Why?
|
Vasoactive Intestinal Peptide | 1 | 2000 | 180 | 0.170 |
Why?
|
Leg | 3 | 2013 | 1089 | 0.170 |
Why?
|
Education, Continuing | 1 | 2020 | 114 | 0.170 |
Why?
|
Incidence | 12 | 2019 | 21322 | 0.170 |
Why?
|
Reproducibility of Results | 11 | 2022 | 20078 | 0.170 |
Why?
|
Vision, Ocular | 5 | 2016 | 454 | 0.160 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2024 | 740 | 0.160 |
Why?
|
Survival Analysis | 8 | 2018 | 10075 | 0.160 |
Why?
|
Ankle Brachial Index | 2 | 2023 | 163 | 0.160 |
Why?
|
Diet, Sodium-Restricted | 1 | 2021 | 291 | 0.160 |
Why?
|
Arrhythmia, Sinus | 1 | 1998 | 48 | 0.160 |
Why?
|
Feedback, Physiological | 3 | 2010 | 476 | 0.160 |
Why?
|
Decision Making | 5 | 2018 | 3923 | 0.160 |
Why?
|
Functional Laterality | 3 | 2013 | 2253 | 0.160 |
Why?
|
Patient Selection | 5 | 2017 | 4240 | 0.160 |
Why?
|
Internet | 4 | 2018 | 3092 | 0.160 |
Why?
|
Information Dissemination | 2 | 2018 | 1127 | 0.160 |
Why?
|
Social Isolation | 1 | 2021 | 364 | 0.160 |
Why?
|
Essential Tremor | 1 | 2021 | 157 | 0.160 |
Why?
|
Reference Values | 9 | 2009 | 4921 | 0.160 |
Why?
|
Posterior Cerebral Artery | 2 | 2009 | 35 | 0.160 |
Why?
|
Treatment Outcome | 15 | 2019 | 64591 | 0.160 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2010 | 361 | 0.150 |
Why?
|
Cardiovascular System | 3 | 2023 | 835 | 0.150 |
Why?
|
Parkinsonian Disorders | 1 | 2021 | 284 | 0.150 |
Why?
|
Respiratory Mechanics | 1 | 2002 | 699 | 0.150 |
Why?
|
Mastication | 1 | 1998 | 53 | 0.150 |
Why?
|
Population Surveillance | 1 | 2008 | 2603 | 0.150 |
Why?
|
Awards and Prizes | 1 | 2022 | 360 | 0.150 |
Why?
|
Physical Stimulation | 3 | 2012 | 518 | 0.150 |
Why?
|
Cholinergic Antagonists | 1 | 1999 | 168 | 0.150 |
Why?
|
Postprandial Period | 1 | 1999 | 315 | 0.150 |
Why?
|
Education, Distance | 1 | 2021 | 260 | 0.150 |
Why?
|
Sensation | 3 | 2013 | 337 | 0.150 |
Why?
|
Multivariate Analysis | 12 | 2010 | 12054 | 0.150 |
Why?
|
Coronary Disease | 5 | 2023 | 5919 | 0.150 |
Why?
|
Morbidity | 3 | 2013 | 1750 | 0.150 |
Why?
|
Atherosclerosis | 2 | 2023 | 3407 | 0.150 |
Why?
|
Reminder Systems | 2 | 2011 | 387 | 0.150 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2015 | 1240 | 0.140 |
Why?
|
Practice Guidelines as Topic | 8 | 2021 | 7380 | 0.140 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4430 | 0.140 |
Why?
|
Biphenyl Compounds | 2 | 2013 | 1003 | 0.140 |
Why?
|
Pressoreceptors | 4 | 1992 | 99 | 0.140 |
Why?
|
Climate Change | 1 | 2023 | 493 | 0.140 |
Why?
|
Droxidopa | 1 | 1996 | 10 | 0.140 |
Why?
|
Cerebral Cortex | 5 | 2013 | 5764 | 0.140 |
Why?
|
Hot Temperature | 1 | 2023 | 1440 | 0.140 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 1999 | 306 | 0.140 |
Why?
|
Amino Acids | 2 | 2000 | 1717 | 0.140 |
Why?
|
Evidence-Based Practice | 1 | 2021 | 495 | 0.140 |
Why?
|
Self Efficacy | 2 | 2020 | 635 | 0.140 |
Why?
|
Bacteriuria | 2 | 1995 | 103 | 0.140 |
Why?
|
Thiadiazoles | 1 | 1997 | 64 | 0.140 |
Why?
|
Medication Errors | 2 | 2020 | 783 | 0.140 |
Why?
|
Muscarinic Agonists | 1 | 1997 | 91 | 0.140 |
Why?
|
Osteoporosis | 4 | 2021 | 1603 | 0.140 |
Why?
|
Antiparkinson Agents | 1 | 1997 | 184 | 0.140 |
Why?
|
Caffeine | 2 | 2007 | 700 | 0.140 |
Why?
|
Supination | 4 | 1991 | 70 | 0.140 |
Why?
|
Diffusion Tensor Imaging | 3 | 2018 | 2399 | 0.140 |
Why?
|
Receptors, Muscarinic | 1 | 1997 | 157 | 0.140 |
Why?
|
Digestive System Diseases | 1 | 1998 | 151 | 0.140 |
Why?
|
Temperature | 1 | 2023 | 2228 | 0.140 |
Why?
|
Tilt-Table Test | 3 | 2009 | 79 | 0.140 |
Why?
|
Touch Perception | 1 | 2018 | 106 | 0.140 |
Why?
|
Vasodilation | 3 | 2009 | 961 | 0.140 |
Why?
|
Prognosis | 10 | 2018 | 29551 | 0.130 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2015 | 6019 | 0.130 |
Why?
|
Information Seeking Behavior | 1 | 2017 | 116 | 0.130 |
Why?
|
Disease | 1 | 2002 | 672 | 0.130 |
Why?
|
Institutionalization | 5 | 1994 | 105 | 0.130 |
Why?
|
Drug Monitoring | 2 | 2021 | 961 | 0.130 |
Why?
|
Food | 2 | 1995 | 772 | 0.130 |
Why?
|
Interpersonal Relations | 3 | 2017 | 1436 | 0.130 |
Why?
|
Solubility | 1 | 2018 | 1091 | 0.130 |
Why?
|
Homebound Persons | 1 | 1996 | 49 | 0.130 |
Why?
|
Accidents | 3 | 1990 | 165 | 0.130 |
Why?
|
Cerebral Arteries | 2 | 2002 | 490 | 0.130 |
Why?
|
Health Status Indicators | 2 | 2019 | 968 | 0.130 |
Why?
|
Chi-Square Distribution | 3 | 2010 | 3418 | 0.130 |
Why?
|
Diabetic Neuropathies | 3 | 2006 | 405 | 0.130 |
Why?
|
Feedback | 3 | 2009 | 791 | 0.130 |
Why?
|
Financing, Government | 1 | 2019 | 472 | 0.130 |
Why?
|
Diabetes Mellitus | 4 | 2015 | 5835 | 0.130 |
Why?
|
Nursing Assessment | 1 | 1995 | 106 | 0.130 |
Why?
|
Aspirin | 2 | 2009 | 3134 | 0.130 |
Why?
|
Eye Diseases | 1 | 2001 | 655 | 0.120 |
Why?
|
Reimbursement, Incentive | 1 | 2020 | 540 | 0.120 |
Why?
|
Pyuria | 2 | 1995 | 30 | 0.120 |
Why?
|
Proportional Hazards Models | 8 | 2011 | 12429 | 0.120 |
Why?
|
Nursing Staff | 1 | 2016 | 113 | 0.120 |
Why?
|
Neurotransmitter Agents | 1 | 1999 | 665 | 0.120 |
Why?
|
Chick Embryo | 1 | 1997 | 982 | 0.120 |
Why?
|
Craniocerebral Trauma | 1 | 2019 | 490 | 0.120 |
Why?
|
Polychlorinated Biphenyls | 1 | 1997 | 235 | 0.120 |
Why?
|
Research Design | 3 | 2018 | 6168 | 0.120 |
Why?
|
Encephalitis | 1 | 2019 | 438 | 0.120 |
Why?
|
Muscles | 4 | 1994 | 1575 | 0.120 |
Why?
|
Food Analysis | 1 | 1995 | 103 | 0.120 |
Why?
|
Cerebral Infarction | 2 | 2010 | 982 | 0.120 |
Why?
|
Personnel Selection | 1 | 1996 | 195 | 0.120 |
Why?
|
Drug Prescriptions | 1 | 2004 | 1669 | 0.120 |
Why?
|
Visual Perception | 4 | 2010 | 1379 | 0.120 |
Why?
|
Mental Disorders | 1 | 2014 | 6831 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 700 | 0.120 |
Why?
|
Altitude | 1 | 1995 | 160 | 0.120 |
Why?
|
Feedback, Sensory | 1 | 2014 | 56 | 0.120 |
Why?
|
Linear Models | 8 | 2009 | 5865 | 0.120 |
Why?
|
Cholesterol | 3 | 2012 | 2902 | 0.120 |
Why?
|
Pneumonia | 2 | 1997 | 2140 | 0.120 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1997 | 339 | 0.120 |
Why?
|
Health Records, Personal | 1 | 2015 | 127 | 0.120 |
Why?
|
Visual Cortex | 3 | 2009 | 1094 | 0.110 |
Why?
|
Telemetry | 2 | 2010 | 199 | 0.110 |
Why?
|
Predictive Value of Tests | 9 | 2019 | 15257 | 0.110 |
Why?
|
Electromyography | 3 | 2017 | 1392 | 0.110 |
Why?
|
RNA, Viral | 1 | 2022 | 2846 | 0.110 |
Why?
|
Family Health | 1 | 2019 | 1257 | 0.110 |
Why?
|
Ultrasonography, Doppler | 2 | 2013 | 461 | 0.110 |
Why?
|
Football | 1 | 2019 | 503 | 0.110 |
Why?
|
Retrospective Studies | 21 | 2021 | 80430 | 0.110 |
Why?
|
Motor Cortex | 1 | 2021 | 1003 | 0.110 |
Why?
|
Neural Pathways | 3 | 2021 | 3049 | 0.110 |
Why?
|
Creatine Kinase | 2 | 2003 | 686 | 0.110 |
Why?
|
Preventive Medicine | 1 | 1995 | 246 | 0.110 |
Why?
|
Medication Adherence | 2 | 2019 | 2166 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2019 | 12127 | 0.110 |
Why?
|
Pulmonary Gas Exchange | 1 | 2015 | 379 | 0.110 |
Why?
|
Memory | 4 | 2006 | 2182 | 0.110 |
Why?
|
Calcium Channel Blockers | 2 | 2015 | 694 | 0.100 |
Why?
|
Angiotensinogen | 2 | 2010 | 161 | 0.100 |
Why?
|
Oscillometry | 1 | 2013 | 150 | 0.100 |
Why?
|
Tidal Volume | 1 | 2015 | 487 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1157 | 0.100 |
Why?
|
Thinking | 2 | 2010 | 320 | 0.100 |
Why?
|
Confidence Intervals | 6 | 2017 | 2927 | 0.100 |
Why?
|
Normal Distribution | 1 | 2013 | 272 | 0.100 |
Why?
|
Pandemics | 2 | 2023 | 8623 | 0.100 |
Why?
|
Haloperidol | 1 | 2014 | 389 | 0.100 |
Why?
|
Interview, Psychological | 1 | 1995 | 809 | 0.100 |
Why?
|
Data Interpretation, Statistical | 3 | 2013 | 2691 | 0.100 |
Why?
|
Health Care Surveys | 2 | 1999 | 2425 | 0.100 |
Why?
|
Deglutition Disorders | 1 | 1998 | 627 | 0.100 |
Why?
|
Health Care Costs | 2 | 2017 | 3240 | 0.100 |
Why?
|
User-Computer Interface | 1 | 2018 | 1397 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2019 | 2711 | 0.100 |
Why?
|
Psychomotor Agitation | 1 | 2014 | 304 | 0.100 |
Why?
|
Health Services | 1 | 2017 | 752 | 0.100 |
Why?
|
Social Control, Formal | 1 | 2012 | 108 | 0.100 |
Why?
|
Medical Staff, Hospital | 1 | 2016 | 601 | 0.100 |
Why?
|
Cardiovascular Physiological Phenomena | 4 | 1995 | 241 | 0.100 |
Why?
|
Vagus Nerve | 3 | 2001 | 458 | 0.100 |
Why?
|
Odds Ratio | 9 | 2014 | 9639 | 0.100 |
Why?
|
Animals, Newborn | 1 | 1997 | 2676 | 0.100 |
Why?
|
Muscle, Skeletal | 3 | 2021 | 4923 | 0.100 |
Why?
|
Myocardial Ischemia | 1 | 2002 | 2110 | 0.100 |
Why?
|
Acoustic Stimulation | 1 | 2016 | 1234 | 0.100 |
Why?
|
Medical Informatics | 1 | 2018 | 733 | 0.100 |
Why?
|
Orthostatic Intolerance | 1 | 2011 | 23 | 0.100 |
Why?
|
Affect | 3 | 2006 | 1483 | 0.090 |
Why?
|
Decision Support Techniques | 3 | 2014 | 1998 | 0.090 |
Why?
|
Neuronal Plasticity | 1 | 2020 | 1434 | 0.090 |
Why?
|
Case-Control Studies | 7 | 2018 | 22097 | 0.090 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2013 | 710 | 0.090 |
Why?
|
Cross-Cultural Comparison | 1 | 1994 | 636 | 0.090 |
Why?
|
Postmenopause | 2 | 2001 | 2513 | 0.090 |
Why?
|
Angina Pectoris | 1 | 1995 | 959 | 0.090 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2012 | 152 | 0.090 |
Why?
|
Myocardium | 1 | 2003 | 4700 | 0.090 |
Why?
|
Plethysmography | 1 | 1991 | 175 | 0.090 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2012 | 246 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2011 | 6471 | 0.090 |
Why?
|
Depressive Disorder | 2 | 2011 | 3728 | 0.090 |
Why?
|
Heart Failure | 7 | 2008 | 11653 | 0.090 |
Why?
|
Appointments and Schedules | 2 | 2011 | 443 | 0.090 |
Why?
|
Memory, Short-Term | 3 | 2018 | 981 | 0.090 |
Why?
|
Patient Satisfaction | 1 | 2003 | 3457 | 0.090 |
Why?
|
Guideline Adherence | 3 | 2017 | 2215 | 0.090 |
Why?
|
Sympathetic Nervous System | 3 | 1999 | 518 | 0.090 |
Why?
|
Air Pollutants | 2 | 2014 | 2870 | 0.090 |
Why?
|
Pulmonary Ventilation | 1 | 2012 | 372 | 0.090 |
Why?
|
Systems Analysis | 2 | 2022 | 169 | 0.090 |
Why?
|
Receptors, Angiotensin | 1 | 2010 | 141 | 0.090 |
Why?
|
Morphine | 1 | 2014 | 655 | 0.090 |
Why?
|
Otolithic Membrane | 1 | 2009 | 38 | 0.080 |
Why?
|
Entropy | 3 | 2016 | 210 | 0.080 |
Why?
|
Cardiovascular Agents | 1 | 1996 | 840 | 0.080 |
Why?
|
Program Evaluation | 2 | 2016 | 2493 | 0.080 |
Why?
|
Wounds and Injuries | 3 | 2021 | 2483 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2012 | 4849 | 0.080 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2011 | 251 | 0.080 |
Why?
|
Hypnotics and Sedatives | 1 | 2017 | 1177 | 0.080 |
Why?
|
Uremia | 1 | 1990 | 201 | 0.080 |
Why?
|
Benzodiazepines | 1 | 2015 | 1130 | 0.080 |
Why?
|
Cardiac Volume | 1 | 1990 | 199 | 0.080 |
Why?
|
Choice Behavior | 1 | 2015 | 823 | 0.080 |
Why?
|
Environmental Exposure | 2 | 2014 | 4443 | 0.080 |
Why?
|
Urban Population | 1 | 2017 | 2032 | 0.080 |
Why?
|
Hearing | 1 | 2013 | 501 | 0.080 |
Why?
|
Withholding Treatment | 1 | 2013 | 617 | 0.080 |
Why?
|
Body Mass Index | 6 | 2019 | 12932 | 0.080 |
Why?
|
Databases as Topic | 3 | 1999 | 473 | 0.080 |
Why?
|
Digoxin | 2 | 2000 | 246 | 0.080 |
Why?
|
Diastole | 3 | 1998 | 782 | 0.080 |
Why?
|
Policy Making | 1 | 2012 | 540 | 0.080 |
Why?
|
Algorithms | 3 | 2013 | 14002 | 0.080 |
Why?
|
Beverages | 1 | 1994 | 821 | 0.080 |
Why?
|
Fruit | 1 | 1994 | 1160 | 0.080 |
Why?
|
Health Promotion | 3 | 2021 | 2211 | 0.080 |
Why?
|
Norepinephrine | 3 | 1999 | 897 | 0.080 |
Why?
|
Communication | 3 | 2018 | 3868 | 0.080 |
Why?
|
Program Development | 1 | 2014 | 1297 | 0.080 |
Why?
|
Aortic Valve Stenosis | 2 | 2019 | 2008 | 0.080 |
Why?
|
Research | 1 | 1996 | 1977 | 0.080 |
Why?
|
Young Adult | 8 | 2024 | 59068 | 0.080 |
Why?
|
Home Care Services | 1 | 2014 | 647 | 0.080 |
Why?
|
Prostaglandin Antagonists | 1 | 2007 | 28 | 0.070 |
Why?
|
Health Surveys | 4 | 2019 | 4056 | 0.070 |
Why?
|
Mental Recall | 2 | 2010 | 1213 | 0.070 |
Why?
|
Patient Preference | 1 | 2015 | 924 | 0.070 |
Why?
|
Ankle Joint | 2 | 2010 | 444 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 2 | 2016 | 3629 | 0.070 |
Why?
|
Ligation | 1 | 2008 | 448 | 0.070 |
Why?
|
Psychological Tests | 2 | 2010 | 640 | 0.070 |
Why?
|
Anterior Cerebral Artery | 1 | 2007 | 50 | 0.070 |
Why?
|
Postoperative Complications | 5 | 2023 | 15627 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2004 | 2272 | 0.070 |
Why?
|
Signal Transduction | 2 | 2015 | 23397 | 0.070 |
Why?
|
Musculoskeletal System | 1 | 2009 | 188 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2010 | 943 | 0.070 |
Why?
|
Socioeconomic Factors | 3 | 2013 | 7817 | 0.070 |
Why?
|
Thigh | 1 | 2008 | 241 | 0.070 |
Why?
|
Intelligence Tests | 1 | 2008 | 503 | 0.070 |
Why?
|
Brain Ischemia | 3 | 2013 | 3048 | 0.070 |
Why?
|
Hospitals | 1 | 2020 | 3873 | 0.070 |
Why?
|
Syndrome | 2 | 2004 | 3267 | 0.070 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2007 | 177 | 0.070 |
Why?
|
Employment | 1 | 2013 | 1114 | 0.070 |
Why?
|
Drug Utilization | 3 | 2004 | 1188 | 0.070 |
Why?
|
Clinical Protocols | 2 | 2009 | 1438 | 0.070 |
Why?
|
Sex Distribution | 2 | 2005 | 2281 | 0.070 |
Why?
|
Perception | 1 | 2013 | 1196 | 0.070 |
Why?
|
Leptin | 1 | 2014 | 1593 | 0.070 |
Why?
|
Fingers | 3 | 2006 | 506 | 0.070 |
Why?
|
Brain Mapping | 3 | 2021 | 6603 | 0.070 |
Why?
|
Vasoconstriction | 1 | 2009 | 592 | 0.070 |
Why?
|
Nerve Degeneration | 2 | 2008 | 748 | 0.070 |
Why?
|
Advance Directives | 2 | 2000 | 248 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2000 | 1540 | 0.060 |
Why?
|
Severity of Illness Index | 6 | 2013 | 15820 | 0.060 |
Why?
|
Longevity | 1 | 1993 | 1062 | 0.060 |
Why?
|
Risk | 4 | 2011 | 9605 | 0.060 |
Why?
|
Arthralgia | 1 | 2009 | 463 | 0.060 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2009 | 485 | 0.060 |
Why?
|
Patient Care Team | 1 | 2016 | 2517 | 0.060 |
Why?
|
Exercise Test | 2 | 2007 | 2127 | 0.060 |
Why?
|
Ukraine | 1 | 2005 | 149 | 0.060 |
Why?
|
Medicine, Traditional | 1 | 2005 | 88 | 0.060 |
Why?
|
Research Subjects | 1 | 1987 | 249 | 0.060 |
Why?
|
Compliance | 1 | 2005 | 100 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 8967 | 0.060 |
Why?
|
Hyperhomocysteinemia | 1 | 2005 | 118 | 0.060 |
Why?
|
Social Change | 1 | 2005 | 153 | 0.060 |
Why?
|
Knee Joint | 3 | 2010 | 1673 | 0.060 |
Why?
|
Pyridines | 1 | 1997 | 2868 | 0.060 |
Why?
|
Models, Neurological | 2 | 2004 | 1765 | 0.060 |
Why?
|
Patient Admission | 2 | 2011 | 1367 | 0.060 |
Why?
|
Pancreatectomy | 1 | 2009 | 810 | 0.060 |
Why?
|
Interviews as Topic | 2 | 2012 | 2683 | 0.060 |
Why?
|
Photoplethysmography | 1 | 2005 | 60 | 0.060 |
Why?
|
Nifedipine | 1 | 2005 | 221 | 0.060 |
Why?
|
Hip Fractures | 1 | 1993 | 988 | 0.060 |
Why?
|
Ticlopidine | 1 | 2009 | 730 | 0.060 |
Why?
|
Splanchnic Circulation | 2 | 1995 | 114 | 0.060 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2009 | 578 | 0.060 |
Why?
|
Insurance Claim Review | 2 | 2019 | 735 | 0.060 |
Why?
|
Phenotype | 3 | 2019 | 16585 | 0.060 |
Why?
|
Blood Circulation | 1 | 2005 | 249 | 0.060 |
Why?
|
Genotype | 4 | 2015 | 12976 | 0.060 |
Why?
|
Probability | 1 | 2009 | 2476 | 0.060 |
Why?
|
Aortic Valve | 1 | 2014 | 1960 | 0.060 |
Why?
|
Alzheimer Disease | 5 | 2008 | 8579 | 0.060 |
Why?
|
Narcotics | 1 | 2006 | 336 | 0.060 |
Why?
|
Atrophy | 1 | 2008 | 1631 | 0.060 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2757 | 0.060 |
Why?
|
Administration, Oral | 3 | 2014 | 4010 | 0.050 |
Why?
|
Muscle Relaxation | 1 | 2003 | 138 | 0.050 |
Why?
|
Obesity | 1 | 2006 | 12918 | 0.050 |
Why?
|
Mental Status Schedule | 2 | 2014 | 314 | 0.050 |
Why?
|
Hospitals, Urban | 2 | 2015 | 500 | 0.050 |
Why?
|
Ventricular Function, Left | 1 | 1996 | 3876 | 0.050 |
Why?
|
Health Care Reform | 1 | 2012 | 1245 | 0.050 |
Why?
|
Anthocyanins | 1 | 2023 | 80 | 0.050 |
Why?
|
Problem Solving | 1 | 2005 | 441 | 0.050 |
Why?
|
Physical Fitness | 2 | 2019 | 739 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 2 | 2013 | 1807 | 0.050 |
Why?
|
Echocardiography, Doppler | 2 | 1996 | 898 | 0.050 |
Why?
|
Orientation | 2 | 1994 | 321 | 0.050 |
Why?
|
Muscle Hypotonia | 1 | 1983 | 161 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 1994 | 2367 | 0.050 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2003 | 186 | 0.050 |
Why?
|
Biological Clocks | 1 | 2004 | 316 | 0.050 |
Why?
|
Internal Medicine | 2 | 1996 | 1051 | 0.050 |
Why?
|
Consensus | 2 | 2021 | 3115 | 0.050 |
Why?
|
Hemostasis | 1 | 2004 | 467 | 0.050 |
Why?
|
Heart | 2 | 1997 | 4391 | 0.050 |
Why?
|
Canada | 2 | 2019 | 2119 | 0.050 |
Why?
|
Myocardial Infarction | 3 | 2006 | 11453 | 0.050 |
Why?
|
Unconsciousness | 1 | 2003 | 250 | 0.050 |
Why?
|
Spain | 1 | 2023 | 489 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2001 | 18216 | 0.050 |
Why?
|
Health Status Disparities | 1 | 2013 | 1847 | 0.050 |
Why?
|
Hypesthesia | 1 | 2002 | 107 | 0.050 |
Why?
|
Heart Diseases | 3 | 2011 | 2785 | 0.050 |
Why?
|
Minority Groups | 2 | 1999 | 1201 | 0.050 |
Why?
|
Motor Activity | 2 | 2009 | 2710 | 0.050 |
Why?
|
Breeding | 1 | 2001 | 51 | 0.050 |
Why?
|
Southeastern United States | 1 | 2001 | 91 | 0.050 |
Why?
|
Electricity | 1 | 2002 | 181 | 0.050 |
Why?
|
Peroneal Nerve | 1 | 2001 | 76 | 0.050 |
Why?
|
Elasticity | 1 | 2003 | 653 | 0.050 |
Why?
|
Dementia, Vascular | 1 | 2002 | 122 | 0.050 |
Why?
|
Lung Volume Measurements | 1 | 2002 | 375 | 0.050 |
Why?
|
Nitroprusside | 1 | 2001 | 272 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3510 | 0.050 |
Why?
|
Age Distribution | 2 | 1997 | 2878 | 0.050 |
Why?
|
Risk Reduction Behavior | 1 | 2007 | 1112 | 0.050 |
Why?
|
Electric Stimulation | 2 | 2003 | 1735 | 0.050 |
Why?
|
Visual Acuity | 1 | 2010 | 2662 | 0.050 |
Why?
|
Statistics as Topic | 2 | 2010 | 2357 | 0.050 |
Why?
|
Primary Health Care | 2 | 2011 | 4674 | 0.050 |
Why?
|
Focus Groups | 2 | 2017 | 1404 | 0.050 |
Why?
|
Demography | 1 | 2005 | 1648 | 0.050 |
Why?
|
Recurrence | 5 | 2012 | 8466 | 0.050 |
Why?
|
Mass Screening | 3 | 2011 | 5424 | 0.050 |
Why?
|
Warfarin | 1 | 2009 | 1483 | 0.050 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2318 | 0.050 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2002 | 170 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 1995 | 3996 | 0.040 |
Why?
|
Self Care | 1 | 2005 | 794 | 0.040 |
Why?
|
Phosphites | 1 | 1999 | 3 | 0.040 |
Why?
|
Environment Design | 1 | 2021 | 172 | 0.040 |
Why?
|
Biology | 1 | 2022 | 289 | 0.040 |
Why?
|
Flavonoids | 1 | 2023 | 444 | 0.040 |
Why?
|
Health Policy | 1 | 2012 | 2680 | 0.040 |
Why?
|
Preoperative Care | 1 | 2008 | 2242 | 0.040 |
Why?
|
Darkness | 1 | 1999 | 158 | 0.040 |
Why?
|
Evaluation Studies as Topic | 2 | 1993 | 1627 | 0.040 |
Why?
|
Endorphins | 1 | 1999 | 74 | 0.040 |
Why?
|
Quinuclidinyl Benzilate | 1 | 1999 | 19 | 0.040 |
Why?
|
Embryonic Stem Cells | 1 | 2006 | 1262 | 0.040 |
Why?
|
Apolipoproteins E | 2 | 1996 | 1444 | 0.040 |
Why?
|
Social Behavior | 1 | 2006 | 1132 | 0.040 |
Why?
|
Blood Gas Analysis | 1 | 2000 | 379 | 0.040 |
Why?
|
Troponin I | 1 | 2003 | 635 | 0.040 |
Why?
|
Endothelins | 1 | 1999 | 127 | 0.040 |
Why?
|
Ontario | 1 | 2000 | 399 | 0.040 |
Why?
|
Central Nervous System Stimulants | 1 | 2007 | 1176 | 0.040 |
Why?
|
Remote Sensing Technology | 1 | 2019 | 92 | 0.040 |
Why?
|
Parasympathetic Nervous System | 1 | 1999 | 141 | 0.040 |
Why?
|
Radioimmunoassay | 1 | 1999 | 866 | 0.040 |
Why?
|
Atropine | 1 | 1999 | 244 | 0.040 |
Why?
|
Phenylalanine | 1 | 2000 | 366 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20551 | 0.040 |
Why?
|
Tritium | 1 | 1999 | 707 | 0.040 |
Why?
|
Geniculate Bodies | 1 | 1999 | 160 | 0.040 |
Why?
|
Acute Disease | 3 | 1999 | 7230 | 0.040 |
Why?
|
Heart Conduction System | 2 | 2009 | 1011 | 0.040 |
Why?
|
Retirement | 1 | 2019 | 198 | 0.040 |
Why?
|
Muscarinic Antagonists | 1 | 1999 | 135 | 0.040 |
Why?
|
Qualitative Research | 2 | 2020 | 3008 | 0.040 |
Why?
|
France | 1 | 2019 | 497 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1859 | 0.040 |
Why?
|
Tryptophan | 1 | 2000 | 482 | 0.040 |
Why?
|
Neurologic Examination | 1 | 2021 | 916 | 0.040 |
Why?
|
Ganglionectomy | 1 | 1997 | 11 | 0.040 |
Why?
|
Self Report | 2 | 2019 | 3721 | 0.040 |
Why?
|
Wound Healing | 1 | 1989 | 2799 | 0.040 |
Why?
|
Dental Care | 1 | 1981 | 285 | 0.040 |
Why?
|
Drug Interactions | 1 | 2002 | 1415 | 0.040 |
Why?
|
Stellate Ganglion | 1 | 1997 | 50 | 0.040 |
Why?
|
Washington | 1 | 1998 | 315 | 0.040 |
Why?
|
Sodium, Dietary | 1 | 2021 | 425 | 0.040 |
Why?
|
Cause of Death | 2 | 2019 | 3686 | 0.040 |
Why?
|
Acetylcholine | 1 | 1999 | 628 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2006 | 2188 | 0.040 |
Why?
|
Intubation, Gastrointestinal | 1 | 1998 | 166 | 0.030 |
Why?
|
Progesterone | 1 | 2001 | 742 | 0.030 |
Why?
|
Anti-Anxiety Agents | 1 | 1999 | 397 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 2000 | 539 | 0.030 |
Why?
|
Community Health Services | 1 | 1982 | 656 | 0.030 |
Why?
|
Confusion | 1 | 1999 | 278 | 0.030 |
Why?
|
Carotid Sinus | 2 | 1986 | 44 | 0.030 |
Why?
|
Methods | 1 | 1997 | 1074 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2001 | 2217 | 0.030 |
Why?
|
Embryonic and Fetal Development | 1 | 1997 | 420 | 0.030 |
Why?
|
Netherlands | 1 | 2021 | 2218 | 0.030 |
Why?
|
Animals | 8 | 2006 | 168253 | 0.030 |
Why?
|
Life Tables | 1 | 1996 | 365 | 0.030 |
Why?
|
Pain Measurement | 2 | 2004 | 3546 | 0.030 |
Why?
|
Blood Glucose | 1 | 2010 | 6380 | 0.030 |
Why?
|
Influenza Vaccines | 2 | 2011 | 763 | 0.030 |
Why?
|
Digestion | 1 | 1995 | 53 | 0.030 |
Why?
|
Computer Simulation | 2 | 2004 | 6230 | 0.030 |
Why?
|
Adolescent | 6 | 2015 | 88196 | 0.030 |
Why?
|
Medical Errors | 1 | 2024 | 1260 | 0.030 |
Why?
|
Hand | 1 | 2021 | 902 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10746 | 0.030 |
Why?
|
Fees and Charges | 1 | 1996 | 192 | 0.030 |
Why?
|
Travel | 1 | 2021 | 795 | 0.030 |
Why?
|
Classification | 1 | 2015 | 127 | 0.030 |
Why?
|
Exercise Therapy | 2 | 1994 | 925 | 0.030 |
Why?
|
Drug Therapy, Combination | 3 | 2000 | 6297 | 0.030 |
Why?
|
Medication Reconciliation | 1 | 2016 | 153 | 0.030 |
Why?
|
Sigmoidoscopy | 1 | 1995 | 151 | 0.030 |
Why?
|
Smoking | 1 | 2011 | 9046 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 911 | 0.030 |
Why?
|
Vertigo | 1 | 1996 | 202 | 0.030 |
Why?
|
Decision Trees | 1 | 1996 | 504 | 0.030 |
Why?
|
Estrogens | 1 | 2001 | 1519 | 0.030 |
Why?
|
Internationality | 1 | 2000 | 1001 | 0.030 |
Why?
|
Serotonin | 1 | 1999 | 1040 | 0.030 |
Why?
|
Pharmacoepidemiology | 1 | 1998 | 350 | 0.030 |
Why?
|
Societies, Medical | 2 | 2016 | 3904 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2006 | 3576 | 0.030 |
Why?
|
Range of Motion, Articular | 1 | 2001 | 1585 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1703 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2011 | 4789 | 0.030 |
Why?
|
Metabolic Diseases | 2 | 1999 | 681 | 0.030 |
Why?
|
Adrenergic alpha-1 Receptor Agonists | 1 | 2013 | 18 | 0.030 |
Why?
|
Teaching Rounds | 1 | 2018 | 275 | 0.030 |
Why?
|
Rectal Diseases | 1 | 1995 | 143 | 0.030 |
Why?
|
Education, Medical | 1 | 2005 | 1726 | 0.030 |
Why?
|
Recreation | 1 | 2014 | 125 | 0.030 |
Why?
|
Perceptual Masking | 2 | 2006 | 90 | 0.030 |
Why?
|
Anticoagulants | 1 | 2009 | 4806 | 0.030 |
Why?
|
Finland | 1 | 2014 | 606 | 0.030 |
Why?
|
Radiography | 1 | 2004 | 6963 | 0.030 |
Why?
|
Family Relations | 1 | 2015 | 317 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12969 | 0.030 |
Why?
|
Consciousness | 1 | 1999 | 601 | 0.030 |
Why?
|
Food, Fortified | 1 | 1994 | 189 | 0.030 |
Why?
|
Diffusion | 1 | 1995 | 814 | 0.030 |
Why?
|
Oxygen | 1 | 2024 | 4222 | 0.030 |
Why?
|
Telemedicine | 1 | 2010 | 3027 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2014 | 554 | 0.030 |
Why?
|
Central Nervous System Diseases | 1 | 1997 | 520 | 0.030 |
Why?
|
Patient Participation | 2 | 1995 | 1442 | 0.030 |
Why?
|
Food, Formulated | 1 | 1993 | 101 | 0.030 |
Why?
|
Sampling Studies | 1 | 1993 | 615 | 0.030 |
Why?
|
Endocrine Glands | 1 | 1992 | 102 | 0.020 |
Why?
|
Medical Records | 1 | 2017 | 1407 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6330 | 0.020 |
Why?
|
Cardiac Output | 1 | 1994 | 837 | 0.020 |
Why?
|
Drinking | 1 | 1993 | 199 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2014 | 1379 | 0.020 |
Why?
|
Urinalysis | 1 | 1994 | 368 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2009 | 5359 | 0.020 |
Why?
|
Pulsatile Flow | 1 | 1993 | 321 | 0.020 |
Why?
|
Fecal Incontinence | 1 | 1994 | 241 | 0.020 |
Why?
|
Autopsy | 1 | 1995 | 1005 | 0.020 |
Why?
|
Medical History Taking | 2 | 1986 | 773 | 0.020 |
Why?
|
Hydrocortisone | 1 | 1999 | 1815 | 0.020 |
Why?
|
Vaccination | 2 | 2011 | 3375 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2016 | 802 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2388 | 0.020 |
Why?
|
Hormones | 1 | 1995 | 867 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 931 | 0.020 |
Why?
|
Carbon | 1 | 2014 | 665 | 0.020 |
Why?
|
Nutritional Status | 2 | 2016 | 1612 | 0.020 |
Why?
|
Apoptosis | 1 | 2006 | 9468 | 0.020 |
Why?
|
Pharmaceutical Preparations | 1 | 1999 | 1087 | 0.020 |
Why?
|
Weight Loss | 1 | 2022 | 2683 | 0.020 |
Why?
|
Blood Urea Nitrogen | 1 | 1990 | 186 | 0.020 |
Why?
|
Coma | 1 | 1994 | 484 | 0.020 |
Why?
|
Equipment Design | 2 | 2012 | 3510 | 0.020 |
Why?
|
Stress, Psychological | 1 | 1986 | 4475 | 0.020 |
Why?
|
Japan | 1 | 1994 | 1366 | 0.020 |
Why?
|
Analgesics, Opioid | 2 | 2004 | 3792 | 0.020 |
Why?
|
Emotions | 1 | 2002 | 2735 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5236 | 0.020 |
Why?
|
Spectrum Analysis | 1 | 1992 | 451 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2012 | 847 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2021 | 8522 | 0.020 |
Why?
|
Vitamin D | 1 | 2023 | 3303 | 0.020 |
Why?
|
Vehicle Emissions | 1 | 2014 | 655 | 0.020 |
Why?
|
Electrolytes | 1 | 1990 | 274 | 0.020 |
Why?
|
Licensure | 1 | 2010 | 128 | 0.020 |
Why?
|
Locomotion | 1 | 1992 | 388 | 0.020 |
Why?
|
Health Services Accessibility | 2 | 2021 | 5421 | 0.020 |
Why?
|
Neurons | 1 | 2008 | 9443 | 0.020 |
Why?
|
Survival Rate | 2 | 2013 | 12698 | 0.020 |
Why?
|
Fourier Analysis | 1 | 1990 | 441 | 0.020 |
Why?
|
Skin | 1 | 2003 | 4474 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 1999 | 2646 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3782 | 0.020 |
Why?
|
Nervous System Diseases | 1 | 1999 | 1654 | 0.020 |
Why?
|
Selection, Genetic | 1 | 1993 | 870 | 0.020 |
Why?
|
Physical Examination | 2 | 1986 | 1254 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2011 | 2788 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2012 | 3346 | 0.020 |
Why?
|
Biometry | 1 | 1992 | 562 | 0.020 |
Why?
|
Ultrasonography | 2 | 1993 | 5966 | 0.020 |
Why?
|
Computer Communication Networks | 1 | 2010 | 294 | 0.020 |
Why?
|
Neoplasms | 2 | 2013 | 22083 | 0.020 |
Why?
|
Brain Concussion | 1 | 2019 | 1403 | 0.020 |
Why?
|
Disease Progression | 3 | 2008 | 13484 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7996 | 0.020 |
Why?
|
Dehydration | 1 | 2009 | 216 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4383 | 0.020 |
Why?
|
Baltimore | 1 | 2008 | 231 | 0.020 |
Why?
|
Electroencephalography | 1 | 2023 | 6215 | 0.020 |
Why?
|
Propranolol | 1 | 1989 | 489 | 0.020 |
Why?
|
Personal Autonomy | 1 | 2010 | 304 | 0.020 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 1987 | 22 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 2 | 1989 | 2248 | 0.020 |
Why?
|
Pneumococcal Vaccines | 1 | 2011 | 397 | 0.020 |
Why?
|
Fear | 1 | 1996 | 1471 | 0.020 |
Why?
|
Therapeutic Human Experimentation | 1 | 1987 | 43 | 0.020 |
Why?
|
Muscular Atrophy | 1 | 1990 | 329 | 0.020 |
Why?
|
State Government | 1 | 2010 | 384 | 0.020 |
Why?
|
Sleep Apnea Syndromes | 1 | 1995 | 972 | 0.020 |
Why?
|
Isosorbide | 1 | 1986 | 3 | 0.020 |
Why?
|
Swine | 1 | 1997 | 5915 | 0.020 |
Why?
|
Forearm | 1 | 1989 | 427 | 0.020 |
Why?
|
Diabetes Complications | 1 | 1994 | 1317 | 0.020 |
Why?
|
Fractures, Bone | 1 | 2019 | 2045 | 0.020 |
Why?
|
Tissue and Organ Procurement | 1 | 1995 | 950 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2010 | 5491 | 0.020 |
Why?
|
Alleles | 2 | 1996 | 6908 | 0.020 |
Why?
|
Telephone | 1 | 2010 | 626 | 0.020 |
Why?
|
Massage | 1 | 1986 | 86 | 0.020 |
Why?
|
Energy Intake | 1 | 1994 | 2134 | 0.020 |
Why?
|
Prejudice | 1 | 2010 | 571 | 0.020 |
Why?
|
Dendrites | 1 | 2008 | 475 | 0.020 |
Why?
|
Confidentiality | 1 | 2010 | 609 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2006 | 825 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 609 | 0.020 |
Why?
|
Tissue Donors | 1 | 1995 | 2319 | 0.020 |
Why?
|
Body Height | 1 | 1992 | 1570 | 0.020 |
Why?
|
Social Class | 1 | 2014 | 2003 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2008 | 990 | 0.020 |
Why?
|
Creatinine | 1 | 2010 | 1898 | 0.020 |
Why?
|
Diet | 1 | 2023 | 8058 | 0.020 |
Why?
|
Body Composition | 2 | 2010 | 2421 | 0.020 |
Why?
|
Language | 1 | 1994 | 1537 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3880 | 0.010 |
Why?
|
Reimbursement Mechanisms | 1 | 2010 | 664 | 0.010 |
Why?
|
Cell Count | 1 | 2008 | 1834 | 0.010 |
Why?
|
Valsalva Maneuver | 1 | 2004 | 99 | 0.010 |
Why?
|
Statistics, Nonparametric | 2 | 2002 | 2852 | 0.010 |
Why?
|
Water-Electrolyte Balance | 1 | 1985 | 325 | 0.010 |
Why?
|
Mammography | 1 | 1995 | 2426 | 0.010 |
Why?
|
Individuality | 1 | 1985 | 300 | 0.010 |
Why?
|
Informed Consent | 1 | 2010 | 1006 | 0.010 |
Why?
|
Cough | 1 | 1987 | 594 | 0.010 |
Why?
|
Photic Stimulation | 1 | 2010 | 1971 | 0.010 |
Why?
|
Gene Frequency | 1 | 2010 | 3637 | 0.010 |
Why?
|
Palliative Care | 1 | 1998 | 3585 | 0.010 |
Why?
|
Parents | 1 | 2017 | 3563 | 0.010 |
Why?
|
Health Expenditures | 1 | 2015 | 2353 | 0.010 |
Why?
|
Health Behavior | 1 | 2014 | 2637 | 0.010 |
Why?
|
Isoenzymes | 1 | 1987 | 1688 | 0.010 |
Why?
|
Binomial Distribution | 1 | 2002 | 23 | 0.010 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 1983 | 112 | 0.010 |
Why?
|
Gene Deletion | 1 | 2010 | 2667 | 0.010 |
Why?
|
Pressure | 1 | 2005 | 1155 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 1995 | 3246 | 0.010 |
Why?
|
Internship and Residency | 1 | 1982 | 5866 | 0.010 |
Why?
|
Memory Disorders | 1 | 2008 | 1198 | 0.010 |
Why?
|
Extracellular Space | 1 | 1983 | 563 | 0.010 |
Why?
|
Blotting, Western | 1 | 2006 | 5031 | 0.010 |
Why?
|
Anti-Arrhythmia Agents | 1 | 1983 | 776 | 0.010 |
Why?
|
Peripheral Nerves | 1 | 2002 | 479 | 0.010 |
Why?
|
South Dakota | 1 | 1998 | 32 | 0.010 |
Why?
|
Kansas | 1 | 1998 | 37 | 0.010 |
Why?
|
Brain Stem | 1 | 1983 | 858 | 0.010 |
Why?
|
Community Health Centers | 1 | 1982 | 460 | 0.010 |
Why?
|
Mississippi | 1 | 1998 | 95 | 0.010 |
Why?
|
Emergency Medicine | 1 | 2007 | 1196 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 1983 | 878 | 0.010 |
Why?
|
Diagnosis | 1 | 1999 | 157 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 1983 | 747 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1990 | 3815 | 0.010 |
Why?
|
Pacemaker, Artificial | 1 | 1983 | 808 | 0.010 |
Why?
|
Information Systems | 1 | 1999 | 396 | 0.010 |
Why?
|
Polypharmacy | 1 | 1999 | 305 | 0.010 |
Why?
|
New York | 1 | 1998 | 872 | 0.010 |
Why?
|
Reagent Strips | 1 | 1995 | 39 | 0.010 |
Why?
|
Carboxylic Ester Hydrolases | 1 | 1995 | 99 | 0.010 |
Why?
|
Colony Count, Microbial | 1 | 1995 | 330 | 0.010 |
Why?
|
Drug Therapy | 1 | 1998 | 503 | 0.010 |
Why?
|
Base Sequence | 2 | 1996 | 12449 | 0.010 |
Why?
|
Light | 1 | 1999 | 1351 | 0.010 |
Why?
|
Medical Records Systems, Computerized | 1 | 1999 | 1191 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 1995 | 11095 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1996 | 17639 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14661 | 0.010 |
Why?
|
Physical Endurance | 1 | 1994 | 364 | 0.010 |
Why?
|
Axons | 1 | 1999 | 1673 | 0.010 |
Why?
|
Escherichia coli Infections | 1 | 1995 | 523 | 0.010 |
Why?
|
Ambulatory Care | 1 | 1982 | 2771 | 0.010 |
Why?
|
Rats | 1 | 2006 | 23712 | 0.010 |
Why?
|
Weight Lifting | 1 | 1990 | 126 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2006 | 11526 | 0.010 |
Why?
|
Nitroglycerin | 1 | 1990 | 329 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 1995 | 806 | 0.000 |
Why?
|
Age of Onset | 1 | 1996 | 3302 | 0.000 |
Why?
|
Data Collection | 1 | 1998 | 3321 | 0.000 |
Why?
|
Hypertrophy | 1 | 1990 | 559 | 0.000 |
Why?
|
Temporal Lobe | 1 | 1996 | 1690 | 0.000 |
Why?
|
Medicaid | 1 | 1999 | 2810 | 0.000 |
Why?
|
Bacteria | 1 | 1995 | 2217 | 0.000 |
Why?
|
Quality of Health Care | 1 | 1999 | 4316 | 0.000 |
Why?
|
Databases, Factual | 1 | 1998 | 7948 | 0.000 |
Why?
|
Mice | 1 | 2006 | 81402 | 0.000 |
Why?
|